Exact Mass: 367.128

Exact Mass Matches: 367.128

Found 86 metabolites which its exact mass value is equals to given mass value 367.128, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cambridge id 5960836

N-[2-(4-Chloro-phenyl)-acetyl]-N-(4,7-dimethyl-quinazolin-2-yl)-guanidine

C19H18ClN5O (367.12)


   

4-[(2-Cyclobutylimidazo[4,5-b]pyrazin-3-yl)methyl]-7,8-difluoro-1H-quinolin-2-one

4-({2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl}methyl)-7,8-difluoro-1,2-dihydroquinolin-2-one

C19H15F2N5O (367.1245)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Riodipine

3,5-Dimethyl 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid

C18H19F2NO5 (367.1231)


   

(+)-Clolimalongine

(+)-Clolimalongine

C18H22ClNO5 (367.1186)


   
   

Maybridge3_007620

Maybridge3_007620

C20H21N3O2S (367.1354)


   
   

1-[4-Hydroxy-6-[2-(dimethylamino)ethyl]benzothiazole-2-yl]-3,4-dihydroisoquinoline-6-ol

1-[4-Hydroxy-6-[2-(dimethylamino)ethyl]benzothiazole-2-yl]-3,4-dihydroisoquinoline-6-ol

C20H21N3O2S (367.1354)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-Methylhemeanthidine chloride

N-Methylhemeanthidine chloride

C18H22ClNO5 (367.1186)


   
   
   
   

tris-(1-Benzotriazolyl)methane

tris-(1-Benzotriazolyl)methane

C19H13N9 (367.1294)


   
   

Boc-L-glutamine p-nitrophenylester

Boc-L-glutamine p-nitrophenylester

C16H21N3O7 (367.1379)


   

diethyl-[2-(4-hydroxy-2-methyl-5-oxofuro[3,2-g]chromen-9-yl)oxyethyl]azanium,chloride

diethyl-[2-(4-hydroxy-2-methyl-5-oxofuro[3,2-g]chromen-9-yl)oxyethyl]azanium,chloride

C18H22ClNO5 (367.1186)


   

Riodipine

Riodipine

C18H19F2NO5 (367.1231)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[(2-methoxyphenyl)azo]-3-oxobutyramide

N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[(2-methoxyphenyl)azo]-3-oxobutyramide

C18H17N5O4 (367.128)


   

beta-lactosyl azide

beta-lactosyl azide

C12H21N3O10 (367.1227)


   
   

(R)-(4-(1-CHLOROPYRIDO[3,4-D]PYRIDAZIN-4-YL)-3-METHYLPIPERAZIN-1-YL)(PHENYL)METHANONE

(R)-(4-(1-CHLOROPYRIDO[3,4-D]PYRIDAZIN-4-YL)-3-METHYLPIPERAZIN-1-YL)(PHENYL)METHANONE

C19H18ClN5O (367.12)


   

3-[[(2,3-dimethylanilino)-sulfanylidenemethyl]amino]-1H-indole-2-carboxylic acid ethyl ester

3-[[(2,3-dimethylanilino)-sulfanylidenemethyl]amino]-1H-indole-2-carboxylic acid ethyl ester

C20H21N3O2S (367.1354)


   

2-{1-[2-Amino-2-(4-hydroxy-phenyl)-acetylamino]-2-oxo-ethyl}-5,5-dimethyl-thiazolidine-4-carboxylic acid

2-{1-[2-Amino-2-(4-hydroxy-phenyl)-acetylamino]-2-oxo-ethyl}-5,5-dimethyl-thiazolidine-4-carboxylic acid

C16H21N3O5S (367.1202)


   

(2R)-3-{[1-(5,6-dihydropyridin-2-yl)-2-hydroxy-2-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}ethyl]sulfanyl}-2-acetamidopropanoate

(2R)-3-{[1-(5,6-dihydropyridin-2-yl)-2-hydroxy-2-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}ethyl]sulfanyl}-2-acetamidopropanoate

C17H23N2O5S- (367.1328)


   

(4S)-2-[(S)-[[(2R)-2-amino-2-phenylacetyl]amino]-carboxymethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

(4S)-2-[(S)-[[(2R)-2-amino-2-phenylacetyl]amino]-carboxymethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

C16H21N3O5S (367.1202)


   
   

4-[4-(Benzenesulfonyl)-1-piperazinyl]-2-methylquinoline

4-[4-(Benzenesulfonyl)-1-piperazinyl]-2-methylquinoline

C20H21N3O2S (367.1354)


   

1-(4-Morpholinyl)-2-[2-(phenylmethylthio)-1-benzimidazolyl]ethanone

1-(4-Morpholinyl)-2-[2-(phenylmethylthio)-1-benzimidazolyl]ethanone

C20H21N3O2S (367.1354)


   

6-(4-morpholinyl)-3-(2-phenylethyl)-2-sulfanylidene-1H-quinazolin-4-one

6-(4-morpholinyl)-3-(2-phenylethyl)-2-sulfanylidene-1H-quinazolin-4-one

C20H21N3O2S (367.1354)


   

4-Hydroxybenzoic acid [2-[1-(2-fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester

4-Hydroxybenzoic acid [2-[1-(2-fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester

C21H18FNO4 (367.122)


   

N-[5-(diethylsulfamoyl)-2-methoxyphenyl]-5-methyl-3-isoxazolecarboxamide

N-[5-(diethylsulfamoyl)-2-methoxyphenyl]-5-methyl-3-isoxazolecarboxamide

C16H21N3O5S (367.1202)


   

2-Hydroxy-17beta-estradiol 3-sulfate

2-Hydroxy-17beta-estradiol 3-sulfate

C18H23O6S- (367.1215)


   

4-[3-[[4-(4-fluorophenyl)-1-piperazinyl]-oxomethyl]-2H-isoxazol-5-ylidene]-1-cyclohexa-2,5-dienone

4-[3-[[4-(4-fluorophenyl)-1-piperazinyl]-oxomethyl]-2H-isoxazol-5-ylidene]-1-cyclohexa-2,5-dienone

C20H18FN3O3 (367.1332)


   

N-{(E)-amino[(4,7-dimethylquinazolin-2-yl)amino]methylidene}-2-(4-chlorophenyl)acetamide

N-{(E)-amino[(4,7-dimethylquinazolin-2-yl)amino]methylidene}-2-(4-chlorophenyl)acetamide

C19H18ClN5O (367.12)


   
   
   
   
   
   
   
   

7-O-methylluteone(1-)

7-O-methylluteone(1-)

C21H19O6- (367.1182)


A flavonoid oxoanion obtained by deprotonation of the 5-hydroxy group of 7-O-methylluteone. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-hydroxydebrisoquine O-glucuronide

N-hydroxydebrisoquine O-glucuronide

C16H21N3O7 (367.1379)


   

N-(3-methylbut-2-en-1-yl)-2-sulfanyladenosine

N-(3-methylbut-2-en-1-yl)-2-sulfanyladenosine

C15H21N5O4S (367.1314)


   

N-[2-(4-Chloro-phenyl)-acetyl]-N-(4,7-dimethyl-quinazolin-2-yl)-guanidine

N-{(E)-amino[(4,7-dimethylquinazolin-2-yl)amino]methylidene}-2-(4-chlorophenyl)acetamide

C19H18ClN5O (367.12)


   

APTO-253

APTO-253

C22H14FN5 (367.1233)


APTO-253 (LOR-253) is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 mediates anticancer activity through induction of the Krüppel-like factor 4 (KLF4) tumor suppressor[1][2]. APTO-253 has antiarthritic activity[3].

   

3-hydroxy-6-[2-(1-hydroxypentyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid

3-hydroxy-6-[2-(1-hydroxypentyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid

C16H21N3O5S (367.1202)


   

3-hydroxy-6-[2-(3-hydroxypentyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid

3-hydroxy-6-[2-(3-hydroxypentyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid

C16H21N3O5S (367.1202)


   

8-{[2-(dimethylamino)ethyl]sulfanyl}-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),4,6,8,10,12,14,16-octaene-6,15-diol

8-{[2-(dimethylamino)ethyl]sulfanyl}-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),4,6,8,10,12,14,16-octaene-6,15-diol

C20H21N3O2S (367.1354)


   

8'-chloro-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-4',5-dione

8'-chloro-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-4',5-dione

C18H22ClNO5 (367.1186)


   

3-hydroxy-6-[2-(4-hydroxypentyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid

3-hydroxy-6-[2-(4-hydroxypentyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboximidic acid

C16H21N3O5S (367.1202)


   

8-{[2-(dimethylamino)ethyl]sulfanyl}-6-hydroxy-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),5,7,9,11,13,16-heptaen-15-one

8-{[2-(dimethylamino)ethyl]sulfanyl}-6-hydroxy-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),5,7,9,11,13,16-heptaen-15-one

C20H21N3O2S (367.1354)